Tuesday, May 2, 2017

BRIEF-Concert Pharmaceuticals initiates CTP-543 phase 2 trial in alopecia areata

* Concert Pharmaceuticals initiates ctp-543 phase 2 trial in

alopecia areata

Read more

No comments:

Post a Comment